Life sciences & diagnostics
Every stage. Every gap.
A therapy only helps the patients who get diagnosed, tested and treated. Implementation Support Programs close the evidence, access and utilization gaps at every stage of a product's life.
The roadmap
Three stages. Three gaps.
Regulators and payers ask different questions, so each gets its own evidence.
| Stage | Evidencefor regulators | Accessfor payers and guideline bodies | Utilizationfor health systems and care teams |
|---|---|---|---|
| Before launch | Clinical programPivotal evidence for approval or clearance | ISPThe burden and cost of today's pathway | ISPMap the pathway; Implementation Hubs and a baseline ready |
| Launch | None | ISPEvidence for coverage decisions | ISPThe same Implementation Hubs reach eligible patients |
| After launch | Clinical programNew indications and post-marketing studies | ISPGuideline inclusion and published results | ISPScale to new Implementation Hubs and sustain adoption |
Clinical programs and ISPs run under separate agreements, with separate data and governance. No report combines them.
Why it matters
Ready at every stage.
Implementation Hubs live, workflows built and a baseline measured, ready to reach eligible patients at launch.
Programs governed by nonprofit partners publish their results, whatever they show.
Who is missed, who declines and where the pathway breaks today, so access and utilization programs are ready for them.
For diagnostics
Measure accuracy. Then measure what changes in care.
A clinical program shows the test works. An Implementation Support Program measures whether it gets people diagnosed faster: time to diagnosis, tests completed and follow-up, measured from day one.
Rules in every program
Four rules. No exceptions.
- Sponsor-neutral pathways
The sponsor's product is one option among several, never the default. Sponsor support is disclosed on program materials.
- A firewall for clinicians
Sponsors fund programs. They never see or shape what clinicians see.
- Pathway before product
Before approval, programs work on the disease and the care pathway. They never mention the product.
- Pay for work, never for people
Fair market value for documented work, set in advance. Never tied to a referral, a diagnosis, a treatment decision or a product.
How it starts
From roadmap to results.
Under NDA, sponsors walk us through the path to market.
We place each evidence, access and utilization gap on the timeline.
A written plan for each program, with the evidence intent declared up front.
Programs run at every stage and keep closing the gap.
Talk to us
Bring us your roadmap.
Tell us where the product is headed and where patients fall out of care today.
connect@rabblehealth.com